Patents by Inventor Alexander Khalanskiy

Alexander Khalanskiy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polylactide nanoparticles
    Publication number: 20110293730
    Abstract: A drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across the animal's blood brain barrier. The drug targeting system comprises nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), a pharmacologically active substance which is absorbed to, adsorbed to, and/or incorporated into the nanoparticles, and either contains TPGS or comprises a pluronic 188 surfactant coating deposited on the drug-loaded nanoparticles.
    Type: Application
    Filed: July 20, 2011
    Publication date: December 1, 2011
    Applicant: LTS Lohmann Therapie-Systeme AG
    Inventors: Jörg Kreuter, Svetlana Gelperina, Olga Maksimenko, Alexander Khalanskiy
  • Polylactide nanoparticles
    Patent number: 8003128
    Abstract: A drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across the animal's blood brain barrier. The drug targeting system comprises nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), a pharmacologically active substance which is absorbed to, adsorbed to, and/or incorporated into the nanoparticles, and either contains TPGS or comprises a pluronic 188 surfactant coating deposited on the drug-loaded nanoparticles.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: August 23, 2011
    Assignee: LTS Lohmann Therapie-Systeme AG
    Inventors: Jörg Kreuter, Svetlana Gelperina, Olga Maksimenko, Alexander Khalanskiy
  • Polylactide Nanoparticles
    Publication number: 20090263491
    Abstract: A drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across the animal's blood brain barrier. The drug targeting system comprises nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), a pharmacologically active substance which is absorbed to, adsorbed to, and/or incorporated into the nanoparticles, and either contains TPGS or comprises a pluronic 188 surfactant coating deposited on the drug-loaded nanoparticles.
    Type: Application
    Filed: March 13, 2007
    Publication date: October 22, 2009
    Applicant: LTS LOHMANN THERAPIE-SYSTEME AG
    Inventors: Jorg Kreuter, Svetlana Gelperina, Olga Maksimenko, Alexander Khalanskiy